Harpoon Therapeutics

United States
unknown
unknown
Stage

About

Harpoon Therapeutics is a clinical-stage immuno-oncology company developing a novel class of T cell engagers that leverage the natural power of T cells to target and fight cancer and other diseases.

Explore Harpoon Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.